Industry Outlook
The mucus clearance devices market is set to expand at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2019 to 2027. According to the latest statistics provided by the (World Health Organization) report more than 3 million people die annually due to chronic obstructive pulmonary disease worldwide which equivalent is to 6% of the deaths occurring throughout the globe.
Market Synopsis
Get a sample copy for more information
"Long term exposure to lung irritants makes COPD the most critical respiratory disease"
Chronic obstructive pulmonary disease is dominating the indication segment for mucus clearance devices market. The chief risk factor that contributes towards the occurrence of COPD is the long term exposure to lung irritants which causes damage to the lower reparatory tracts and lung alveoli. Significant rise in the number of smokers worldwide and increasing air pollution at an alarming rate will further accentuate the incidence rate of COPD throughout the globe. Bronchiectasis has gained tremendous attention in the last decade owing to the constant rise in the number of antibiotic resistant patients suffering with acute lung infection.
"High frequency chest wall oscillation (HFCWO) devices are in demand for its excellent ergonomic features which promises patients comfort and associated concordance"
High frequency chest wall oscillation devices are leading the product segment for mucus clearance devices segment. The addition of new ergonomic features such as vibration at varying intensities and frequency in the existing devices promises patient comfort and associated concordance. Increasing demand from homecare settings and rehabilitation centers further propels the HFCWO devices market growth. Oscillating positive expiratory pressure will be showcasing impressive growth in the near future owing to its twin benefits in patients suffering with cystic fibrosis such as clearance of excess fluids from the lungs and significant reduction in gas trapping and improvement in ventilation of the lungs.
Get a sample copy for more information
"Growing incidence of chronic pulmonary obstructive disease and significant rise in smoking population together drive the market growth in North America"
North America accounts for a market share of 35.1% and is the dominating regional segment for mucus clearance devices market. Growing incidence of chronic pulmonary disease and subsequent growth in the smoking population together drive the market growth in North America region. According to the research findings of Center for Disease Control and Prevention (CDC), 2017 report the number of deaths in the U.S. due to chronic lower respiratory tract disease is 160,201, hence making it the 4th largest causes of death in the region. Europe holds a market share of 29.5% primarily due to high prevalence rate of cystic fibrosis in the European Union which is 0.79 per 10,000 people as quoted by European Respiratory Society (ERS). Asia Pacific represents 16.8% market share owing to the significant rise in tobacco consumption and developing healthcare infrastructure.
Get a sample copy for more information
Historical & Forecast Period
This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.
Report Scope by Segments
The market segmentation comprises of by indication, product and geography.
| ATTRIBUTE |
DETAILS |
| Research Period |
2017-2027 |
| Base Year |
2018 |
| Forecast Period |
2019-2027 |
| Historical Year |
2017 |
| Unit |
USD Million |
| Segmentation |
By Indication (2017–2027; US$ Mn)
• Bronchiectasis
• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease
• Others
|
|
By Product (2017–2027; US$ Mn)
• High Frequency Chest Wall Oscillation Device
• Intrapulmonary Percussive Ventilation Flutter Device
• Oscillating Positive Expiratory Pressure Device
|
|
Geography Segment (2017–2027; US$ Mn)
• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
Medical device companies manufacturing mucus clearance devices are Allergan, Plc., Electromed, Inc., Hill-Rom, Inc., Koninklijke Philips N.V., Monaghan Medical Corporation, Respiratory Technologies, Inc., Smiths Medical, Thayer Medical Corporation and Vortran Medical Technology 1, Inc.
Key questions answered in this report
- Which medical device manufacturers are pioneering in the production of mucus clearance devices?
- What are the strategic collaboration, merger and acquisitions happening in the mucus clearance devices market?
- What is the incidence rate of chronic respiratory ailments?
- What are the latest ergonomic features added to the existing mucus clearance devices?
- What is the prevalence rate of COPD and Bronchiectasis in developing regional segments?
